Cargando…

Immunogenetics of new onset diabetes after transplantation in Kuwait

Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identified....

Descripción completa

Detalles Bibliográficos
Autores principales: Jahromi, Mohamed, Al-Otaibi, Torki, Othman, Nashwa, Gheith, Osama, Mahmoud, Tarek, Nair, Prasad, Halim, Medhat A, Nampoory, Narayanam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535099/
https://www.ncbi.nlm.nih.gov/pubmed/31190933
http://dx.doi.org/10.2147/DMSO.S195859
_version_ 1783421543168081920
author Jahromi, Mohamed
Al-Otaibi, Torki
Othman, Nashwa
Gheith, Osama
Mahmoud, Tarek
Nair, Prasad
Halim, Medhat A
Nampoory, Narayanam
author_facet Jahromi, Mohamed
Al-Otaibi, Torki
Othman, Nashwa
Gheith, Osama
Mahmoud, Tarek
Nair, Prasad
Halim, Medhat A
Nampoory, Narayanam
author_sort Jahromi, Mohamed
collection PubMed
description Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identified. We aimed to investigate NODAT among kidney transplant cohort in Kuwait with special stress on correlation between its risk factors and interferon gamma genotyping. Materials and methods: We surveyed 309 kidney transplant recipients from Hamed Al Essa Transplantation Centre, Kuwait. The participants were categorized into cohorts according to the development of NODAT diagnosed based on the American Diabetes Association guidelines. Statistical analyses were performed using SPSS software. We genotyped interferon gamma as the leading immunosignature for T lymphocyte. Results: No relationship between ethnicity and the development of NODAT was identified. However, there was a significant difference in age between cohorts. Younger patients demonstrated a lower rate of NODAT while, NODAT reached its maximum in 40–60-year age group. IFNG TT genotype was significantly associated with NODAT (p=0.005), while IFNG AA was considerably higher in the non-NODAT group. Conclusion: Beside the conventional contributing factors of NODAT, our results might represent a suitable platform for a larger cytokine and chemokine spectrum genotyping.
format Online
Article
Text
id pubmed-6535099
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-65350992019-06-12 Immunogenetics of new onset diabetes after transplantation in Kuwait Jahromi, Mohamed Al-Otaibi, Torki Othman, Nashwa Gheith, Osama Mahmoud, Tarek Nair, Prasad Halim, Medhat A Nampoory, Narayanam Diabetes Metab Syndr Obes Original Research Introduction and aim: New onset diabetes after transplantation (NODAT) is a serious metabolic complication following kidney transplantation. Although beta-cell dysfunction is considered the main contributing factor in the development of this complication, its exact etiology is yet to be identified. We aimed to investigate NODAT among kidney transplant cohort in Kuwait with special stress on correlation between its risk factors and interferon gamma genotyping. Materials and methods: We surveyed 309 kidney transplant recipients from Hamed Al Essa Transplantation Centre, Kuwait. The participants were categorized into cohorts according to the development of NODAT diagnosed based on the American Diabetes Association guidelines. Statistical analyses were performed using SPSS software. We genotyped interferon gamma as the leading immunosignature for T lymphocyte. Results: No relationship between ethnicity and the development of NODAT was identified. However, there was a significant difference in age between cohorts. Younger patients demonstrated a lower rate of NODAT while, NODAT reached its maximum in 40–60-year age group. IFNG TT genotype was significantly associated with NODAT (p=0.005), while IFNG AA was considerably higher in the non-NODAT group. Conclusion: Beside the conventional contributing factors of NODAT, our results might represent a suitable platform for a larger cytokine and chemokine spectrum genotyping. Dove 2019-05-20 /pmc/articles/PMC6535099/ /pubmed/31190933 http://dx.doi.org/10.2147/DMSO.S195859 Text en © 2019 Jahromi et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jahromi, Mohamed
Al-Otaibi, Torki
Othman, Nashwa
Gheith, Osama
Mahmoud, Tarek
Nair, Prasad
Halim, Medhat A
Nampoory, Narayanam
Immunogenetics of new onset diabetes after transplantation in Kuwait
title Immunogenetics of new onset diabetes after transplantation in Kuwait
title_full Immunogenetics of new onset diabetes after transplantation in Kuwait
title_fullStr Immunogenetics of new onset diabetes after transplantation in Kuwait
title_full_unstemmed Immunogenetics of new onset diabetes after transplantation in Kuwait
title_short Immunogenetics of new onset diabetes after transplantation in Kuwait
title_sort immunogenetics of new onset diabetes after transplantation in kuwait
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535099/
https://www.ncbi.nlm.nih.gov/pubmed/31190933
http://dx.doi.org/10.2147/DMSO.S195859
work_keys_str_mv AT jahromimohamed immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT alotaibitorki immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT othmannashwa immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT gheithosama immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT mahmoudtarek immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT nairprasad immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT halimmedhata immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait
AT nampoorynarayanam immunogeneticsofnewonsetdiabetesaftertransplantationinkuwait